Related references
Note: Only part of the references are listed.PerturbationAnalyzer: a tool for investigating the effects of concentration perturbation on protein interaction networks
Fei Li et al.
BIOINFORMATICS (2010)
Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells
Ping Shi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells
U. Rix et al.
LEUKEMIA (2010)
Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
Armin Wolf et al.
LEUKEMIA RESEARCH (2010)
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
Jiannong Li et al.
NATURE CHEMICAL BIOLOGY (2010)
Database resources of the National Center for Biotechnology Information
Eric W. Sayers et al.
NUCLEIC ACIDS RESEARCH (2010)
MINT, the molecular interaction database: 2009 update
Arnaud Ceol et al.
NUCLEIC ACIDS RESEARCH (2010)
The IntAct molecular interaction database in 2010
B. Aranda et al.
NUCLEIC ACIDS RESEARCH (2010)
The Universal Protein Resource (UniProt) in 2010
Rolf Apweiler et al.
NUCLEIC ACIDS RESEARCH (2010)
Network analyses in systems pharmacology
Seth I. Berger et al.
BIOINFORMATICS (2009)
The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network
Mingzhu Zhu et al.
JOURNAL OF DRUG TARGETING (2009)
Acid Elution and One-Dimensional Shotgun Analysis on an Orbitrap Mass Spectrometer: An Application to Drug Affinity Chromatography
Nora V. Fernbach et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib
Disha Dumka et al.
LEUKEMIA & LYMPHOMA (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Target profiling of small molecules by chemical proteomics
Uwe Rix et al.
NATURE CHEMICAL BIOLOGY (2009)
Proteomics strategy for quantitative protein interaction profiling in cell extracts
Kirti Sharma et al.
NATURE METHODS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Human Protein Reference Database-2009 update
T. S. Keshava Prasad et al.
NUCLEIC ACIDS RESEARCH (2009)
Network Properties of Complex Human Disease Genes Identified through Genome-Wide Association Studies
Fredrik Barrenas et al.
PLOS ONE (2009)
Charting the molecular network of the drug target Bcr-Abl
Marc Brehme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identifying the proteins to which small-molecule probes and drugs bind in cells
Shao-En Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib and Abl/Lyn inhibitor INNO-406 in newly established K562 variants with BCR-ABL gene amplification
Koji Morinaga et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Drug target identification using side-effect similarity
Monica Campillos et al.
SCIENCE (2008)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)
Drug-target network
Muhammed A. Yildirim et al.
NATURE BIOTECHNOLOGY (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Propagation of large concentration changes in reversible protein-binding networks
Sergei Maslov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The human disease network
Kwang-Il Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma
C. E. Ford et al.
BRITISH JOURNAL OF CANCER (2007)
A human phenome-interactome network of protein complexes implicated in genetic disorders
Kasper Lage et al.
NATURE BIOTECHNOLOGY (2007)
Innovation - A robustness-based approach to systems-oriented drug design
Hiroaki Kitano
NATURE REVIEWS DRUG DISCOVERY (2007)
Global topological features of cancer proteins in the human interactome
Pall F. Jonsson et al.
BIOINFORMATICS (2006)
BioGRID: a general repository for interaction datasets
Chris Stark et al.
NUCLEIC ACIDS RESEARCH (2006)
Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues
S Wachi et al.
BIOINFORMATICS (2005)
NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia
S Kimura et al.
BLOOD (2005)
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein
Y Ishihama et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Robustness of the p53 network and biological hackers
L Dartnell et al.
FEBS LETTERS (2005)
Network structures and algorithms in Bioconductor
VJ Carey et al.
BIOINFORMATICS (2005)
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2
Y Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The Database of Interacting Proteins: 2004 update
L Salwinski et al.
NUCLEIC ACIDS RESEARCH (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Share Paper
